Here's why some people still get COVID even after being vaccinated and double-boosted

日本 ニュース ニュース

Here's why some people still get COVID even after being vaccinated and double-boosted
日本 最新ニュース,日本 見出し
  • 📰 abc13houston
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 63%

'This (BA.2.12.1) is now the most transmissible subvariant we have of all,' said Dr. Monica Gandhi of UCSF. 'It now looks like it's 30% more transmissible than BA.2 alone.'

SAN FRANCISCO -- The highly contagious omicron subvariant BA.2.12.1 accounts for roughly 37% of new COVID cases nationwide.

"This is now the most transmissible subvariant we have of all," said Dr. Monica Gandhi, MD, MPH, UCSF Infectious Disease expert and added,"it now looks like it's 30% more transmissible than BA.2 alone." Dr. Gandhi says that even if you are vaccinated, double boosted and doing everything right this subvariant can still infect you.

"You got a vaccine that looks like the old strain of the virus and there are 32 mutations across the spike protein that omicron has. So, the antibodies which is this defense up here don't work as well, but your deep defense down in the lungs and your ability to still protect yourself from severe disease the vaccine still works," said Dr. Gandhi.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

abc13houston /  🏆 255. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Why Even A Less Effective COVID-19 Vaccine Is Worth GettingWhy Even A Less Effective COVID-19 Vaccine Is Worth GettingThe mRNA COVID-19 vaccines available in the United States work. But how well they work, by what metrics and for whom … that’s all unfortunately in flux.  S…
続きを読む »

China medical experts say zero-COVID strategy buys time to vaccinate more peopleChina medical experts say zero-COVID strategy buys time to vaccinate more peopleChina's tough zero-COVID measures remain essential to defeat the pandemic and buy time to improve vaccination rates and develop new treatments, senior health advisers wrote in recently published reports.
続きを読む »

Covid: Fourth-dose jab trial shows good boostCovid: Fourth-dose jab trial shows good boostBut scientists say any short-term protection against infection is likely to fall away quickly.
続きを読む »

Here’s Why the FDA Has Restricted Johnson & Johnson’s COVID-19 VaccineHere’s Why the FDA Has Restricted Johnson & Johnson’s COVID-19 VaccineThe update follows a similar CDC recommendation.
続きを読む »



Render Time: 2025-03-04 08:07:23